At the International Conference on Frailty and Sarcopenia Research in Toulouse, France, CDO Ann Neale presented data from BioAge's successful Phase 1 trial of our muscle aging drug BGE-105.
January 26, 2023
Kristen Fortney on Bio Eats World
CEO & co-founder Kristen Fortney joined Vijay Pande, founding partner of a16z Bio + Health, in a discussion spanning the biology of aging, BioAge’s mission to fight age-related disease…and how long a _hypothetical_ venture capitalist can expect to live.
January 21, 2023
Dr. Eric Morgen on the Talking Biotech podcast
COO & co-founder Eric Morgen talks about aging as a risk for chronic disease, and BioAge’s approach to developing therapeutics that might slow or prevent age-related disorders.
January 4, 2023
Virtual KOL event for apelin receptor agonist BGE-105
BioAge leadership described target discovery by our AI-driven platform, clinical development, and the positive data from our Phase 1b trial, and two world-leading experts explained the clinical importance of muscle aging and the acute myopathies to be addressed in Phase 2.